650 related articles for article (PubMed ID: 21035550)
21. Design and evaluation of folate-appended α-, β-, and γ-cyclodextrins having a caproic acid as a tumor selective antitumor drug carrier in vitro and in vivo.
Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H
Biomacromolecules; 2013 Dec; 14(12):4420-8. PubMed ID: 24175976
[TBL] [Abstract][Full Text] [Related]
22. GSH and enzyme responsive nanospheres based on self-assembly of green tea polyphenols and BSA used for target cancer chemotherapy.
Zhang J; Ren X; Tian X; Zhang P; Chen Z; Hu X; Mei X
Colloids Surf B Biointerfaces; 2019 Jan; 173():654-661. PubMed ID: 30368213
[TBL] [Abstract][Full Text] [Related]
23. Charge-conversional and reduction-sensitive poly(vinyl alcohol) nanogels for enhanced cell uptake and efficient intracellular doxorubicin release.
Chen W; Achazi K; Schade B; Haag R
J Control Release; 2015 May; 205():15-24. PubMed ID: 25445693
[TBL] [Abstract][Full Text] [Related]
24. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
25. Multifunctional DNA-gold nanoparticles for targeted doxorubicin delivery.
Alexander CM; Hamner KL; Maye MM; Dabrowiak JC
Bioconjug Chem; 2014 Jul; 25(7):1261-71. PubMed ID: 24911830
[TBL] [Abstract][Full Text] [Related]
26. Folic acid-capped PEGylated magnetic nanoparticles enter cancer cells mostly via clathrin-dependent endocytosis.
Allard-Vannier E; Hervé-Aubert K; Kaaki K; Blondy T; Shebanova A; Shaitan KV; Ignatova AA; Saboungi ML; Feofanov AV; Chourpa I
Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1578-1586. PubMed ID: 27919801
[TBL] [Abstract][Full Text] [Related]
27. Folate mediated self-assembled phytosterol-alginate nanoparticles for targeted intracellular anticancer drug delivery.
Wang J; Wang M; Zheng M; Guo Q; Wang Y; Wang H; Xie X; Huang F; Gong R
Colloids Surf B Biointerfaces; 2015 May; 129():63-70. PubMed ID: 25829128
[TBL] [Abstract][Full Text] [Related]
28. Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance.
Wang H; Yin H; Yan F; Sun M; Du L; Peng W; Li Q; Feng Y; Zhou Y
Oncotarget; 2015 Feb; 6(5):2827-42. PubMed ID: 25605018
[TBL] [Abstract][Full Text] [Related]
29. Delivery of Doxorubicin for Human Cervical Carcinoma Targeting Therapy by Folic Acid-Modified Selenium Nanoparticles.
Xia Y; Xu T; Zhao M; Hua L; Chen Y; Wang C; Tang Y; Zhu B
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30428576
[TBL] [Abstract][Full Text] [Related]
30. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.
Qiu LY; Yan L; Zhang L; Jin YM; Zhao QH
Int J Pharm; 2013 Nov; 456(2):315-24. PubMed ID: 24016742
[TBL] [Abstract][Full Text] [Related]
31. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
[TBL] [Abstract][Full Text] [Related]
32. Folate-decorated maleilated pullulan-doxorubicin conjugate for active tumor-targeted drug delivery.
Zhang H; Li F; Yi J; Gu C; Fan L; Qiao Y; Tao Y; Cheng C; Wu H
Eur J Pharm Sci; 2011 Apr; 42(5):517-26. PubMed ID: 21352909
[TBL] [Abstract][Full Text] [Related]
33. Preparation of magnetically responsive albumin nanospheres and in vitro drug release studies.
Ak G; Yɪlmaz H; Sanlɪer SH
Artif Cells Nanomed Biotechnol; 2014 Feb; 42(1):18-26. PubMed ID: 23419121
[TBL] [Abstract][Full Text] [Related]
34. Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery.
Cao W; Zhou J; Mann A; Wang Y; Zhu L
Biomacromolecules; 2011 Jul; 12(7):2697-707. PubMed ID: 21619062
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxicity of folic acid conjugated hollow silica nanoparticles toward Caco2 and 3T3 cells, with and without encapsulated DOX.
Patel K; Sundara Raj B; Chen Y; Lou X
Colloids Surf B Biointerfaces; 2016 Apr; 140():213-222. PubMed ID: 26764104
[TBL] [Abstract][Full Text] [Related]
36. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
[TBL] [Abstract][Full Text] [Related]
37. A folate modified pH sensitive targeted polymeric micelle alleviated systemic toxicity of doxorubicin (DOX) in multi-drug resistant tumor bearing mice.
Li X; Yang X; Lin Z; Wang D; Mei D; He B; Wang X; Wang X; Zhang Q; Gao W
Eur J Pharm Sci; 2015 Aug; 76():95-101. PubMed ID: 25917524
[TBL] [Abstract][Full Text] [Related]
38. Self-organized nanoparticles based on chitosan-folic acid and dextran succinate-doxorubicin conjugates for drug targeting.
Lee KD; Choi SH; Kim DH; Lee HY; Choi KC
Arch Pharm Res; 2014 Dec; 37(12):1546-53. PubMed ID: 25280540
[TBL] [Abstract][Full Text] [Related]
39. Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes.
Wen S; Liu H; Cai H; Shen M; Shi X
Adv Healthc Mater; 2013 Sep; 2(9):1267-76. PubMed ID: 23447549
[TBL] [Abstract][Full Text] [Related]
40. Hyaluronic acid nanogels with enzyme-sensitive cross-linking group for drug delivery.
Yang C; Wang X; Yao X; Zhang Y; Wu W; Jiang X
J Control Release; 2015 May; 205():206-17. PubMed ID: 25665867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
